FGAM
NVAX icon

Financial Gravity Asset Management’s Novavax NVAX Stock Holding History

Financial Gravity Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7
Closed -$31 – 1673
2024
Q1 		$31 Buy
7
+4
+133% +$19 ﹤0.01% 1082
2023
Q4 		$16 Buy
+3
New +$18 ﹤0.01% 1241
2021
Q3 		$207K Hold
1
– – 0.1% 171
2021
Q2 		$212K Buy
+1
New +$183 0.08% 176
2020
Q4 		$0 Buy
+2
New +$213 ﹤0.01% 619

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Financial Gravity Asset Management's NVAX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Novavax (NVAX) in Q2 2024, closing a stake of 7 shares — an estimated $31 sold.

Financial Gravity Asset Management first reported a position in NVAX in Q4 2020 and held it in 5 quarters. The position peaked at $212K in Q2 2021. 230 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 7 Novavax shares in Q2 2024, an estimated $31.
  • Financial Gravity Asset Management first reported a position in Novavax in Q4 2020 and held it in 5 quarters.
  • Financial Gravity Asset Management's Novavax position peaked at $212K in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.